Mitglied werden

Merck & Co., Inc. (MRK)

Healthcare • Drug Manufacturers - General

48
Beobachten
$113,37
Kurs
+2,81%
Veränderung
283,17 Mrd. $
Marktkapitalisierung
-
KGV

Neumann-Score Aktienanalyse

48
von 100 Punkten
Beobachten
Bewertung??/100
Profitabilität??/100
Wachstum??/100

Score-Details freischalten

Werden Sie Mitglied und erhalten Sie Zugang zu allen Analysen.

Mitglied werden

Über Merck & Co., Inc.

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, p ...

CEO
Robert Davis
Mitarbeiter
73.000
Land
US